Metastatic Colorectal Cancers Terminated Phase 3 Trials for Masitinib (DB11526)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02605044Masitinib in Combination With FOLFIRI for Second-line Treatment of Patients With Metastatic Colorectal CancerTreatment